Indoco Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indoco Remedies Limited has informed stock exchanges that its trading window for dealing in equity shares will remain closed from 1st October 2025 until 48 hours after the declaration of unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2025. During this period, all designated persons of the company, including their immediate relatives, have been advised not to trade in the company's shares. The exact date of the board meeting to approve the Q2/H1 FY26 results will be communicated later. This is a routine compliance filing under SEBI's insider trading regulations.
This is a standard regulatory disclosure and does not have a direct impact on stock price or shareholders. Investors should watch for the upcoming Q2 FY26 results announcement, which will be the next material event for the stock.